Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.

Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.

Item
http://www.wikidata.org/entity/Q43850341
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in SpainPercutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.Effect of weight loss on urinary incontinence in womenThe effect of sacral neuromodulation on anticholinergic use and expenditures in a privately insured populationPreventing kidney injury in children with neurogenic bladder dysfunction.Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015).Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up.Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System.Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy?Bladder augmentation and urinary diversion for neurogenic LUTS: current indications
P2860

Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.

Item
http://www.wikidata.org/entity/Q43850341
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Cost analysis of interventions ...... ients with overactive bladder.
@en
Cost analysis of interventions ...... ients with overactive bladder.
@nl
type
label
Cost analysis of interventions ...... ients with overactive bladder.
@en
Cost analysis of interventions ...... ients with overactive bladder.
@nl
prefLabel
Cost analysis of interventions ...... ients with overactive bladder.
@en
Cost analysis of interventions ...... ients with overactive bladder.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Cost analysis of interventions ...... ients with overactive bladder.
@en
P2093
P304
P31
P356
10.1016/J.UROLOGY.2010.01.080
P407
P433
P478
P577
P698